Role of zoledronic acid in treating osteoporosis in post-allogeneic bone marrow transplant patients - A phase II trial.

被引：0
|
作者：
Chamarthy, Usha
Rao, D. Sudhaker
Divine, George
Khan, Shahzad
Janakiraman, Nalini
机构：
[1] Henry Ford Hlth Syst, Bone & Mineral Metab, Hematol Oncol Bone Marrow Transplantat, Detroit, MI USA
[2] Sparrow Reg Canc Ctr, Lansing, MI USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2971.2971
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2971
引用
收藏
页码：842A / 842A
页数：1
相关论文
共 50 条
  • [41] A prospective Phase II study for the efficacy of radiotherapy in combination with zoledronic acid in treating painful bone metastases from gastrointestinal cancers
    Choi, Jinhyun
    Lee, Eun Jung
    Yang, Seung Hyun
    Im, Yoo Ri
    Seong, Jinsil
    JOURNAL OF RADIATION RESEARCH, 2019, 60 (02) : 242 - 248
  • [42] Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer
    Di Lorenzo, Giuseppe
    Autorino, Riccardo
    Giuliano, Mario
    Morelli, Emilio
    Giordano, Antonio
    Napodano, Giorgio
    Russo, Aniello
    Benincasa, Giuseppe
    D'Armiento, Massimino
    Altieri, Vincenzo
    De Placido, Sabino
    UROLOGY, 2007, 69 (02) : 347 - 351
  • [43] PILOT TRIAL OF ALLOGENEIC TRANSPLANT COMBINING PERIPHERAL-BLOOD AND BONE-MARROW IN PATIENTS WITH REFRACTORY HEMATOLOGIC MALIGNANCY
    NEMUNAITIS, J
    ROSENFELD, C
    COLLINS, R
    PINEIRO, L
    OHR, S
    PALLANSCH, P
    SHADDUCK, R
    STONE, M
    FAY, J
    BLOOD, 1993, 82 (10) : A417 - A417
  • [44] PILOT TRIAL OF PROPHYLACTIC URSODIOL TO DECREASE THE INCIDENCE OF VENOOCCLUSIVE DISEASE OF THE LIVER IN ALLOGENEIC BONE-MARROW TRANSPLANT PATIENTS
    ESSELL, JH
    THOMPSON, JM
    HARMAN, GS
    HALVORSON, RD
    SNYDER, MJ
    CALLANDER, NS
    CLEMENT, DJ
    BONE MARROW TRANSPLANTATION, 1992, 10 (04) : 367 - 372
  • [45] Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial
    Lipplaa, Astrid
    Kroep, Judith R.
    van der Heijden, Lizz
    Jutte, Paul C.
    Hogendoorn, Pancras C. W.
    Dijkstra, Sander
    Gelderblom, Hans
    ONCOLOGIST, 2019, 24 (07): : 889 - +
  • [46] A Phase IB/II Study of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or Marrow Transplant (alloBMT) Remission Maintenance
    Webster, Jonathan Allen
    Jones, Richard J.
    Blackford, Amanda
    Shedeck, Audra
    Ambinder, Richard F.
    Swinnen, Lode J.
    Wagner-Johnston, Nina
    Fuchs, Ephraim Joseph
    Bolanos-Meade, Javier
    Imus, Philip
    Bonifant, Challice L.
    Symons, Heather Jill
    Jain, Tania
    Prince, Gabrielle T.
    Levis, Mark J.
    Luznik, Leo
    Gojo, Ivana
    BLOOD, 2023, 142
  • [47] Role of azithromycin in bronchiolitis obliterans obliterative bronchiolitis in post-bone marrow transplant (BMT) patients
    Khalid, M
    Saghir, A
    Sahovic, E
    Chaudhry, N
    Al Jurf, M
    Al Dammas, S
    Al Mobeireek, A
    Zeitouni, M
    CHEST, 2003, 124 (04) : 172S - 172S
  • [48] Bone-marrow sparing IMRT for anal cancer patients: a prospective phase II trial
    Arcadipane, F.
    Silvetti, P.
    Fiandra, C.
    Gallio, E.
    Martini, S.
    Giglioli, F.
    Sardo, A.
    Iorio, G. C.
    Olivero, F.
    Gastino, A.
    De Luca, V.
    Ricardi, U.
    Franco, P.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S296 - S297
  • [49] FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients
    Peter A Fasching
    Sebastian M Jud
    Maik Hauschild
    Sherko Kümmel
    Martin Schütte
    Matthias Warm
    Volker Hanf
    Dieter Grab
    Jutta Krocker
    Elmar Stickeler
    Rolf Kreienberg
    Thomas Müller
    Thorsten Kühn
    Christopher Wolf
    Steffen Kahlert
    Stefan Paepke
    Michael Berghorn
    Mathias Muth
    Monika Baier
    Birgit Wackwitz
    Rüdiger Schulz-Wendtland
    Matthias W Beckmann
    Michael P Lux
    BMC Cancer, 14
  • [50] RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients
    L A Kachnic
    S L Pugh
    P Tai
    M Smith
    E Gore
    A B Shah
    A-G Martin
    H E Kim
    A Nabid
    C A F Lawton
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 382 - 386
12345